Issue |
Title |
File |
Vol 10, No 1 (2016) |
Evaluation of the level of substance P in patients with ischemic stroke in the acute phase |
|
Levashova O.A., Kukhtevich I.I., Zolkornyaev I.G., Aleshina N.I., Kuptsova M.F.
|
Vol 13, No 3 (2019) |
Exosomal Transport and Progression of Neurodegeneration in Amyotrophic Lateral Sclerosis |
|
Ivanova M.V., Chekanova E.O., Belugin B.V., Tutykhina I.L., Dolzhikova I.V., Zakroishchikova I.V., Vasil’ev A.V., Zakharova M.N.
|
Vol 12, No 3 (2018) |
Exosome Drug Delivery through the Blood–Brain Barrier: Experimental Approaches and Potential Applications |
|
Druzhkova T.A., Yakovlev A.A.
|
Vol 13, No 4 (2019) |
Expression of Neurotrophic Factor 3 in the Hippocampus of Neonatal Rats after Administration of Dexamethasone |
|
Bulygina V.V., Kalinina T.S., Lanshakov D.A., Dygalo N.N.
|
Vol 13, No 2 (2019) |
Expression of Vascular Endothelial Growth Factor in the Rat Brain after Perinatal Hypoxia and Pharmacological Correction |
|
Mironova V.I., Akulova V.K., Khozhai L.I., Pritvorova A.V., Ordyan N.E., Otellin V.A.
|
Vol 10, No 1 (2016) |
Gender differences in the plasma lipid profile and cellular lipid peroxidation intensity in diabetic patients with distal symmetrical polyneuropathy |
|
Djordjevic G., Ljubisavljevic S.
|
Vol 11, No 4 (2017) |
Gene expression and the contents of noradrenaline synthesis enzymes in the rat brain during the critical period of morphogenesis |
|
Murtazina A.R., Nikishina Y.O., Bondarenko N.S., Sapronova A.Y., Volina E.V., Ugryumov M.V.
|
Vol 13, No 2 (2019) |
Genes Encoding Erythropoietin and Its Receptor in Bipolar I (Manic Phase) Patients as a Novel Diagnostic Agent: A Case-Control Study |
|
Moradi M., Saidijam M., Ghaleiha A., Jahangard L., Yadegarazari R., Keshavarzi A.
|
Vol 10, No 2 (2016) |
Glutamate excitotoxicity and oxidative stress induced by experimental thrombosis of retinal vessels |
|
Kolesnikov A.V., Shchul’kin A.V., Yakusheva E.N., Barenina O.I., Uzbekov M.G., Kudrin V.S., Klodt P.M., Ostrovskaya R.U.
|
Vol 13, No 1 (2019) |
Glutamate Signaling Defects in Propionic Acid Orally Administered to Juvenile Rats as an Experimental Animal Model of Autism |
|
Al-Suwailem E., Abdi S., Bhat R.S., El-Ansary A.
|
Vol 10, No 1 (2016) |
Heterogeneous choline acetyltransferase staining in cholinergic neurons |
|
Kolos E.A., Korzhevskii D.A.
|
Vol 11, No 2 (2017) |
Hypothetical neurochemical mechanisms of paradoxical sleep deficiency in Alzheimer’s disease |
|
Silkis I.G.
|
Vol 10, No 2 (2016) |
Immunolocalization of gaseous neurotransmitters in interneurons in the medulla oblongata in rats |
|
Chertok V.M., Kotsyuba A.E., Startseva M.S., Kotsyuba E.P.
|
Vol 10, No 3 (2016) |
Immunological study of freshwater crayfish nervous tissue for receptors for neurotrophins and ciliary neurotrophic factor |
|
Kolosov M.S., Komandirov M.A., Terent’ev V.V., Shitov A.V., Kiroy R.I., Kurayan O.E.
|
Vol 10, No 1 (2016) |
Increased intake of fat and cholesterol as a pathogenetic factor of depression: A possible molecular mechanism |
|
Veniaminova E.A., Strekalova T.V.
|
Vol 10, No 2 (2016) |
Increased ratios of homocysteine/vitamin B12, homocysteine/folate and methionine/vitamin B12 in schizophrenic patients |
|
Kulaksızoglu B., Kulaksızoglu S., Ellidag H.Y., Cinemre B., Baykal A., Yılmaz N.
|
Vol 13, No 3 (2019) |
Influence of Loranthus micranthus against STZ-Induced Neurobehavioral Deficits in Diabetic Rats |
|
Ebokaiwe A.P., Ijomone O.M., Osawe S.O., Osuji O., Alo M.
|
Vol 12, No 4 (2018) |
Interaction between Hydrogen Sulfide and Muscarinic Receptors in the Regulation of Contractility of the Mouse Atrium |
|
Blokhina A.S., Khaertdinov N.N., Zefirov A.L., Sitdikova G.F.
|
Vol 13, No 1 (2019) |
Involvement of CA1 GABAA Receptors in Ketamine-Induced Impairment of Spatial and Non-Spatial Novelty Detection in Mice |
|
Khanegheini A., Meftahi G.H., Zarrindast M.R., Afarinesh M.R., Sahraei H., Jahromi G.P., Shahyad S.
|
Vol 13, No 4 (2019) |
Lipid Peroxidation and the Antioxidant System in the Blood of Epileptic Patients |
|
Zharkinbekova N.A., Ormanov N.Z.
|
Vol 13, No 4 (2019) |
Lipid Peroxidation Products in the Blood Plasma of Patients with Parkinson’s Disease as Possible Biomarkers of Different Stages of the Disease |
|
Fedorova T.N., Logvinenko A.A., Poleshchuk V.V., Muzychuk O.A., Shabalina A.A., Illarioshkin S.N.
|
Vol 12, No 1 (2018) |
Long-Term Changes in Behavior and the Content of BDNF in the Rat Brain Caused by Neonatal Isolation: The Effects of an Analog of ACTH(4-10) Semax |
|
Sukhanova Y.A., Volodina M.A., Sebentsova E.A., Glazova N.Y., Manchenko D.M., Inozemtseva L.S., Andreeva L.A., Dolotov O.V., Levitskaya N.G.
|
Vol 10, No 4 (2016) |
Markers of structural and functional impairments of the central nervous system in an experimental model of thiopental coma |
|
Shvetsov A.V., Batotsyrenova E.G., Stepanov S.V., Ivanov M.B.
|
Vol 11, No 4 (2017) |
Mechanisms of the development and integration of nerve processes: Age-related dynamics of the development of absence epilepsy, changes in the concentration of monoamines and their metabolites in the brain structures of WAG/Rij and Wistar rats, and the dynamics of the disruption of learning and memory |
|
Fedosova E.A., Folomkina A.A., Kulikov M.A., Kudrin V.S., Narkevich V.B., Bazyan A.S.
|
Vol 12, No 1 (2018) |
Melatonin Modulates Phosphorylation of 2′,3′-Cyclic Nucleotide-3′-Phosphodiesterase in the Presence of Protoporphyrin IX in the Brain Mitochondria of Rats during the Functioning of the Non-Specific Mitochondrial Pore |
|
Krestinina O.V., Baburina Y.L., Odinokova I.V., Azarashvili T.S., Akatov V.S.
|
51 - 75 of 194 Items |
<< < 1 2 3 4 5 6 7 8 > >> |